"Sinopsis" puede pertenecer a otra edición de este libro.
From the reviews:
“This book summarizes the translational research in the development of glutamate-based approaches to treat psychiatric disorders. Written and edited by an international group of researchers, it is an important addition to the psychiatric literature. ... The intended audience includes psychiatric researchers and psychiatrists. Neuroscientists interested in the treatment of patients with psychiatric disorders also would benefit from reading this book. ... The index is quite helpful. ... presents a unique and novel approach that is desperately needed in the treatment of these difficult disorders.” (Michael Joel Schrift, Doody’s Review Service, February, 2011)"Sobre este título" puede pertenecer a otra edición de este libro.
Gastos de envío:
EUR 2,44
A Estados Unidos de America
Descripción Condición: New. Nº de ref. del artículo: 11627461-n
Descripción Hardcover. Condición: new. Nº de ref. del artículo: 9783034602402
Descripción Condición: New. Nº de ref. del artículo: ABLIING23Mar3113020037570
Descripción Condición: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Nº de ref. del artículo: ria9783034602402_lsuk
Descripción Condición: New. Nº de ref. del artículo: 11627461-n
Descripción Buch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Both metabotropic and ionotropic glutamate receptors present attractive 'druggable' targets in treating disorders of the central nervous system. There has been a dramatic shift in the focus of glutamate-based therapies away from neurologic disorders such as stroke and traumatic brain injury to the treatment of psychiatric disorders. This 'Milestones in Drug Therapy' volume offers a unique, contemporary overview of preclinical and clinical evidence that modulating glutamatergic tone is an effective means of treating psychiatric disorders ranging from depression and anxiety to schizophrenia and drug abuse. The ability to treat diseases such as depression and schizophrenia through multiple, glutamate-based mechanisms offers a unique therapeutic opportunity, as described in this book. 192 pp. Englisch. Nº de ref. del artículo: 9783034602402
Descripción Gebunden. Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Contemporary monograph on glutamate-based approaches to treat psychiatric drugs The approaches described in this text exploit both metabotropic and ionotropic glutamate receptors Focus on translational research, with many of the authors coming from industr. Nº de ref. del artículo: 4317895
Descripción Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Both metabotropic and ionotropic glutamate receptors present attractive 'druggable' targets in treating disorders of the central nervous system. There has been a dramatic shift in the focus of glutamate-based therapies away from neurologic disorders such as stroke and traumatic brain injury to the treatment of psychiatric disorders. This 'Milestones in Drug Therapy' volume offers a unique, contemporary overview of preclinical and clinical evidence that modulating glutamatergic tone is an effective means of treating psychiatric disorders ranging from depression and anxiety to schizophrenia and drug abuse. The ability to treat diseases such as depression and schizophrenia through multiple, glutamate-based mechanisms offers a unique therapeutic opportunity, as described in this book. Nº de ref. del artículo: 9783034602402
Descripción Hardcover. Condición: Brand New. 1st edition. 178 pages. 10.00x6.50x0.75 inches. In Stock. Nº de ref. del artículo: x-3034602405
Descripción Nº de ref. del artículo: STOCK12060307